
Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
KMTS · cash on hand · updated Apr 30, 2025
Core cash position
as of Apr 30, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthKestra Medical Technologies, Ltd. has a net cash position of $193.3M, holding more cash than debt.
Cash on hand history
Annual cash on hand by year
KMTS cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Kestra Medical Technologies, Ltd. (KMTS) cash on hand as of April 30, 2025 is $237.6M, comprising $237.6M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Kestra Medical Technologies, Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Kestra Medical Technologies, Ltd. cash reserves or cash position.
Kestra Medical Technologies, Ltd. annual cash on hand history shows increased +2780.3% in 2025: increased +2780.3% in 2025. Kestra Medical Technologies, Ltd. cash reserves in 2025 reflect the company's capital allocation strategy.
Kestra Medical Technologies, Ltd. carries total debt of $44.3M against cash of $237.6M, resulting in a net cash position of +$193.3M. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
KMTS cash on hand · 5 questionsAs of April 30, 2025, Kestra Medical Technologies, Ltd. (KMTS) has $237,595,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $237,595,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (January 31, 2026): $291,321,000. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Kestra Medical Technologies, Ltd. · Kestra Medical Technologies, Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: April 30, 2025